News

< Back

New Report looks at 10 years of the New Investigators Awards in Alzheimer’s Disease program


The Rosalinde and Arthur Gilbert Foundation and AFAR have published the report, “New Investigator Awards in Alzheimer’s Disease Research: A Successful Model for Investing in Futures.”


The report looks at the first ten years of the New Investigator Awards in Alzheimer’s Disease research program and describes the program’s evolution, accomplishments, responsiveness to emerging needs in the field, and lessons learned.

We hope the report will be of value to others who are committed to advancing research and career development in Alzheimer’s disease.

The full report can be downloaded here.

Since 2007, The Rosalinde and Arthur Gilbert Foundation has invested $3.7 million to support New Investigators in the United States and Israel conducting Alzheimer’s disease research.

For a complete list of New Investigators to date, please click here.
To learn more about the program, please click here.

AFAR is grateful to The Rosalinde and Arthur Gilbert Foundation for their collaboration and generous support of this program.

More Recent News

View All News >
Ask the Expert Interview: Economist and author Andrew J. Scott, MSc, DPhil, on The Longevity Imperative
Ask the Expert Interview: Economist and author Andrew J. Scott, MSc, DPhil, on The Longevity Imperative
AFAR Grantee in the News: Pinchas Cohen, MD, elected as a 2024 Fellow of the American Association for the Advancement of Science
AFAR Grantee in the News: Pinchas Cohen, MD, elected as a 2024 Fellow of the American Association for the Advancement of Science
AFAR Initiative in the News: NPR spotlights TAME Trial and AFAR Scientific Leadership
AFAR Initiative in the News: NPR spotlights TAME Trial and AFAR Scientific Leadership
Announcing the Second Cohort of the Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
Announcing the Second Cohort of the Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience Research
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD, on “Why Do We Age?” in The New York Times
AFAR Experts in the News: Andrew Dillin, PhD, and Matt Kaeberlein, PhD, on “Why Do We Age?” in The New York Times
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Live Better Longer column launches with Prevention: Debut Article Spotlights SuperAgers Family Study
AFAR Grantee in the News: Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Grantee in the News:  Matt Kaeberlein, PhD, in GQ on the longevity gap between the sexes
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Leadership in the News: AFAR Scientific Director Nir Barzilai, MD, on the presidential candidates’ health in The New York Times
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell
AFAR Experts in the News: Seven AFAR experts co-author new research on a genetic mutation that could promote longevity and protect those predisposed to Alzheimer’s in Aging Cell